Term
| Chlorpromazine (trade name) |
|
Definition
|
|
Term
| Chlorpromazine (therapeutic class) |
|
Definition
| Conventional antipsychotic |
|
|
Term
| Chlorpromazine (therapeutic use) |
|
Definition
| Symptomatic relief of positive symptoms of schizophrenia, and controls manic symptoms in patients with schitzoaffective disorder |
|
|
Term
| Chlorpromazine (pharm class) |
|
Definition
| Phenothiazine; D2 dopamine receptor antagonist |
|
|
Term
|
Definition
| Blockade of D2 dopamine receptors |
|
|
Term
|
Definition
|
|
Term
| Haloperidol (therapeutic class) |
|
Definition
| Conventional antipsychotic |
|
|
Term
| Haloperidol (therapeutic use) |
|
Definition
| Management of acute and chronic psychotic disorders |
|
|
Term
| Haloperidol (pharm class) |
|
Definition
| Nonphenothiazine; D2 dopamine receptor antagonist |
|
|
Term
| Haloperidol (pharm class) |
|
Definition
| Nonphenothiazine; D2 dopamine receptor antagonist |
|
|
Term
|
Definition
| Blockade of D2 dopamine receptors |
|
|
Term
|
Definition
|
|
Term
| Risperidone (therapeutic class) |
|
Definition
|
|
Term
| Risperidone (therapeutic use) |
|
Definition
| Treatment and prevention of schizophrenia relapse; treatment of bipolar mania symptoms; treatment of symptoms of irritability in autistic children |
|
|
Term
| Risperidone (pharm class) |
|
Definition
| D2 dopamine receptor antagonist (weak affinity for D1 receptor) and 5-HT2 receptor antagonist |
|
|
Term
|
Definition
| Blockade of D2 dopamine receptors, 5-HT2 receptors, & alpha2 receptors in CNS |
|
|
Term
| Risperidone (additional info.) |
|
Definition
| Sometimes combined with lithium or valproate for more complete effectiveness |
|
|
